$37.76
-2.39 (-5.95%)
ATRC News2 articles
Boston Scientific Tumbles 16% on Watchman Slowdown; Focus Shifts to Monday's Reaction
Boston Scientific shares fell 16.4% last week after CEO Michael Mahoney warned of declining Watchman usage and flat growth through Q3. Wells Fargo downgraded the stock and slashed its price target.
Markets React to Geopolitical Tensions and Corporate Governance Moves
Global equities faced pressure Thursday as renewed geopolitical worries in West Asia rattled Indian and Asian benchmarks. Meanwhile, corporate news centered on governance shifts at Obayashi and valuation reviews for Rio Tinto and AtriCure.